Compliance Risk Assessment in Life Sciences: Why Proactive Monitoring Matters
The Stakes Compliance risk assessment in life sciences is no longer just a periodic exercise. Life sciences is one of the most enforcement heavy industries in the world. Pharmaceutical and biotech companies face layered regulations governing HCP interactions, promotional practices, clinical research, pricing, and financial transparency. When compliance fails, the consequences are measured in billions. […]
